M. Rubio-Rivas

Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry

Miguel Ángel Martínez, Yale Tung Chen, Manuel Cebrian, 2023, Internal and Emergency Medicine.

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohnâ•Žs disease

Jesús, Gianluca, Annette Lee, 2020 .

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry☆

J. Casas-Rojo, S. Freire-Castro, F. Carrasco-Sánchez, 2020, Revista Clínica Española (English Edition).

through the

J. M. Fernández-Rodríguez, N. Lorenzo-Villalba, J. García-Klepzig, 2013 .

Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

R. Ríos-Fernandez, N. Ortego-Centeno, J. Callejas, 2018, Rheumatology International.

Immunoglobulins in systemic sclerosis management. A large multicenter experience.

I. Castellví, C. Simeón-Aznar, J. Pego-Reigosa, 2023, Autoimmunity reviews.

through the

J. M. Fernández-Rodríguez, N. Lorenzo-Villalba, J. García-Klepzig, 2022 .

Prevalence of the limited vs. extensive Scleroderma-interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis.

M. Pestaña-Fernández, M. Rubio-Rivas, 2024, Revista clinica espanola.